Skip to content
Search AI Powered

Latest Stories

NHSE to put ‘blood in pee’ cancer warnings on urinal mats in pubs, football grounds

NHSE to put ‘blood in pee’ cancer warnings on urinal mats in pubs, football grounds

Nearly half of men surveyed thought blood in pee was not a symptom of cancer

The UK's National Health Service (NHS) has partnered with P-Wave, a urinal products brand, to put cancer warnings for men on urinal mats in public places across England, as part of its new earlier diagnosis drive.


Urinal mats in pubs, restaurants, shops, hotels and sports stadiums will begin to carry the message “Blood in your pee? Contact your GP practice”, and men’s toilets in workplaces will also be targeted, the NHS said.

Health chiefs believe that this unique initiative will help men to spot the signs of cancer such as blood in pee, and catch the disease early.

“Having blood in your pee – even just once – shouldn’t be ignored because it can be a sign of cancer, so it needs to be checked out by your GP team,” said Professor Peter Johnson, NHS England National Clinical Director for Cancer.

“Cancer survival is at an all-time high, and we’re seeing more cancers than ever before being picked up at an early stage – and this partnership with P-wave is just one of the many ways we are helping people to be aware of possible cancer symptoms,” he added.

It is easier to treat can when diagnosed early, the NHS noted while urging people to be aware of changes in their bodies.

Passing blood in pee is a common symptom for bladder, kidney and prostate cancers, which are among the 10 most prevalent cancers in England, and they generally affect men more than women.

Other common symptoms associated with these cancers include peeing very often, sudden urges to pee or a burning sensation when you pee, difficulty peeing, a lump or swelling in your back, under your ribs, or in your neck, or pain in the side between the ribs and the hip.

Dave Carson, P-Wave Managing Director, commented: “We are proud to be working with NHS England on this first-of-its-kind partnership, which offers a creative yet simple way to convey a potentially life-saving cancer awareness message.

“We are delighted that through our P-Wave urinal mats, we can encourage people to check for blood in their pee and to contact their GP practice if they spot it and are excited to share these with our customers and play a part in helping spread this important message.”

The NHSE came up with the cancer catching drive after a survey found that nearly half of men thought blood in pee was not a symptom of cancer.

In the survey, two-fifths (39 per cent) of men said they would wait until they’ve noticed blood in their pee multiple times before seeing a GP.

Further it revealed that over half of men in England use a public urinal at least once a week, and the majority of men surveyed said they would be more likely to contact their GP practice if they saw messaging on a urinal mat and were experiencing blood in their pee.

The NHS has taken up various initiatives, including community lung health checks, to achieve its goal of diagnosing three quarters of all cancers at stage one or two by 2028.

Nearly three million people received lifesaving checks for cancer last year, which was more than any other year on record, the NHS revealed.

Screenshot 2023 12 07 195320

More For You

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Prakash Patel was speaking at a panel discussion at the Sigma Conference

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Pharmacists need to be a part of integrated care boards (ICB) to stop GPs from monopolising services based on their needs rather than the needs of the patient, according to Prakash Patel, Community Pharmacy Engaland (CPE) representative for North London.

“The evolution of the NHS should mean there can be no decision of pharmacy without pharmacist,” Patel told delegates at the Sigma Pharmacy Conference in Baku, Azerbaijan on Tuesday.

Keep ReadingShow less
New professional liability insurance policy for RPS members launched

The insurance will be provided to members at cost, with no profit made by RPS.

gettyimages

RPS launches professional liability insurance for members

The Royal Pharmaceutical Society (RPS) has launched a new professional liability insurance policy, designed to empower pharmacists to work confidently and deliver high-quality care, knowing they are protected.

Exclusively available to its members, the comprehensive and affordable insurance has been developed in collaboration with global professional services firm Aon.

Keep ReadingShow less
Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less